{"id":"W2527584789","doi":"10.1200/jco.2013.31.15_suppl.3620","title":"Overall survival (OS) analysis from PRIME: Randomized phase III study of panitumumab (pmab) with FOLFOX4 for first-line metastatic colorectal cancer (mCRC).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Credit Valley Hospital; Mount Sinai Hospital","funders":"","keywords":"KRAS; Medicine; Colorectal cancer; Clinical endpoint; Internal medicine; Exon; Oncology; Panitumumab; Primary tumor; Randomized controlled trial; Cancer; Metastasis; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003294504,0.001390802,0.001636267,0.0003728662,0.0002509386,0.0006110138,0.0007030734,0.000789921,0.004466879],"category_scores_gemma":[0.001615705,0.0005930835,0.002026102,0.0002893473,0.0007534145,0.0006671491,0.000476619,0.002585383,0.000483024],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009151925,"about_ca_system_score_gemma":0.001521414,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006955035,"about_ca_topic_score_gemma":0.00192224,"domain_scores_codex":[0.9992059,0.0005178773,0.00002590906,0.00009406599,0.00006531551,0.00009098061],"domain_scores_gemma":[0.9990003,0.0002472299,0.000268257,0.0000930992,0.00004685444,0.0003443363],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9594154,0.006579492,0.003060994,0.0003572397,0.001009694,0.0000560701,0.00004456239,0.001044482,0.006276459,0.00007382142,0.001244996,0.02083678],"study_design_scores_gemma":[0.7010585,0.2720069,0.01893163,0.00003696482,0.001848795,0.0001668296,0.00001812929,0.001367199,0.002552222,0.0002293372,0.001762536,0.00002092801],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904363,0.001711092,0.000842782,0.0003174229,0.00009521025,0.002620132,0.00205899,0.000108506,0.001809589],"genre_scores_gemma":[0.9886661,0.0009030233,0.001970134,0.0004994532,0.0001347582,0.002746954,0.00298352,0.00003081882,0.002065299],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004466879,"threshold_uncertainty_score":0.01742315,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1059472628263756,"score_gpt":0.4678299087986043,"score_spread":0.3618826459722286,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}